SS
GSK icon

SBI Securities’s GSK GSK Stock Holding History

SBI Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Sell
36,393
-780
-2% -$41.3K 0.04% 196
2026
Q1 		$2.05M Sell
37,173
-46
-0.1% -$2.49K 0.06% 174
2025
Q4 		$1.83M Sell
37,219
-571
-2% -$26.6K 0.05% 195
2025
Q3 		$1.63M Sell
37,790
-21
-0.1% -$820 0.04% 215
2025
Q2 		$1.45M Buy
37,811
+1,666
+5% +$63.7K 0.04% 220
2025
Q1 		$1.4M Buy
36,145
+2,569
+8% +$94K 0.05% 203
2024
Q4 		$1.14M Buy
+33,576
New +$1.21M 0.04% 238

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SBI Securities's GSK Position: Q2 2026 in Review

SBI Securities reduced its GSK (GSK) stake by 2.1% in Q2 2026, selling an estimated $41.3K and leaving 36,393 shares worth $1.91M. The position accounts for 0.04% of the portfolio, ranked #196.

SBI Securities first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.05M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • SBI Securities held 36,393 shares of GSK worth $1.91M as of Q2 2026.
  • SBI Securities sold 780 GSK shares in Q2 2026, an estimated $41.3K.
  • GSK made up 0.04% of SBI Securities's portfolio in Q2 2026, its #196 holding.
  • SBI Securities first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's GSK position peaked at $2.05M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.